TAM
AMED

Townsend Asset Management’s Amedisys AMED Stock Holding History

Townsend Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,864
Closed -$278K – 212
2021
Q3 		$278K Hold
1,864
– – 0.15% 117
2021
Q2 		$457K Hold
1,864
– – 0.25% 81
2021
Q1 		$494K Hold
1,864
– – 0.31% 69
2020
Q4 		$547K Sell
1,864
-231
-11% -$59.2K 0.36% 66
2020
Q3 		$495K Sell
2,095
-35
-2% -$7.96K 0.4% 64
2020
Q2 		$423K Sell
2,130
-75
-3% -$14K 0.34% 79
2020
Q1 		$405K Sell
2,205
-15
-0.7% -$2.67K 0.42% 63
2019
Q4 		$371K Buy
+2,220
New +$330K 0.3% 88

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Townsend Asset Management's AMED Position: Q4 2021 in Review

Townsend Asset Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 1,864 shares — an estimated $278K sold.

Townsend Asset Management first reported a position in AMED in Q4 2019 and held it in 8 quarters. The position peaked at $547K in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Townsend Asset Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Townsend Asset Management sold 1,864 Amedisys shares in Q4 2021, an estimated $278K.
  • Townsend Asset Management first reported a position in Amedisys in Q4 2019 and held it in 8 quarters.
  • Townsend Asset Management's Amedisys position peaked at $547K in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Townsend Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.